TY - JOUR
T1 - Genetics and autoantibodies
AU - Perricone, Carlo
AU - Agmon-Levin, Nancy
AU - Ceccarelli, Fulvia
AU - Valesini, Guido
AU - Anaya, Juan Manuel
AU - Shoenfeld, Yehuda
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 2013/7
Y1 - 2013/7
N2 - Autoimmune diseases (ADs) are chronic conditions initiated by the loss of immunological tolerance to self-antigens. The pathogenic hypothesis comprises a complex interaction between genetic, environmental and hormonal factors that interact with an individual over time generating a dysregulation of the immune system leading to disease development. Several polymorphic genes contribute to the development of ADs. Furthermore, age and gender play a major role by influencing hormone levels that can represent the fulcrum unbalancing from susceptibility to protection. Evidences suggest that while all these steps occur, the susceptible individual develops autoantibodies over a long time lapse. Such autoantibody production is genetically determined and finally, their presence seems to determine the clinical presentation of ADs. The genetic predisposition to the developments of autoantibodies and toward the disease process may overlap. The unveiling of these mechanisms could allow not only to treat but also to prevent the development of autoimmune diseases.
AB - Autoimmune diseases (ADs) are chronic conditions initiated by the loss of immunological tolerance to self-antigens. The pathogenic hypothesis comprises a complex interaction between genetic, environmental and hormonal factors that interact with an individual over time generating a dysregulation of the immune system leading to disease development. Several polymorphic genes contribute to the development of ADs. Furthermore, age and gender play a major role by influencing hormone levels that can represent the fulcrum unbalancing from susceptibility to protection. Evidences suggest that while all these steps occur, the susceptible individual develops autoantibodies over a long time lapse. Such autoantibody production is genetically determined and finally, their presence seems to determine the clinical presentation of ADs. The genetic predisposition to the developments of autoantibodies and toward the disease process may overlap. The unveiling of these mechanisms could allow not only to treat but also to prevent the development of autoimmune diseases.
UR - https://www.scopus.com/pages/publications/84879550144
UR - https://www.scopus.com/pages/publications/84879550144#tab=citedBy
U2 - 10.1007/s12026-013-8396-9
DO - 10.1007/s12026-013-8396-9
M3 - Research Article
C2 - 23564181
AN - SCOPUS:84879550144
SN - 0257-277X
VL - 56
SP - 206
EP - 219
JO - Immunologic Research
JF - Immunologic Research
IS - 2-3
ER -